Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: a retrospective analysisResearch in context by Adriana M. Ivama-Brummell, Fernanda L. Marciniuk, Anita K. Wagner, Claudia G.S. Osorio-de-Castro, Sabine Vogler, Elias Mossialos, Carla L. Tavares-de-Andrade, Huseyin Naci

Get full text